跳至主要内容
临床试验/DRKS00032548
DRKS00032548尚未招募不适用

Antithrombotic strategies for treatment of patients with ventricular thrombus after myocardial infarction and association of outcomes: a retrospective analysis

niversitätsklinikum Freiburg0 个研究点目标入组 200 人开始时间: 2023年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • - Myocardial infarction (STEMI or NSTEMI) with PCI prior to diagnosis of the ventricular thrombus and within the same hospitalization
  • - Ventricular thrombus confirmed by TTE and/or cardiac MR
  • - Initiation of oral anticoagulation treatment

排除标准

  • - Patients with anticoagulation therapies other than DOAC or Marcumar

研究者

相似试验

尚未招募
Unknown
Optimal antithrombotic strategy for treatment of atherosclerotic cardiovascular disease – comparison of clopidogrel-based antiplatelet agent treatment versus aspirin plus low dose rivaroxaban therapy (OACART study)
KCT0008458Seoul National University Bundang Hospital2,758
撤回
不适用
Antithrombotic Treatment in patients with Effectively Maintained Sinus rhythm after Atrial Fibrillation ablatio
KCT0000535Koera University Guro Hospital750
未知
不适用
management of antithrombotic therapy for nonvariceal upper gastrointestinal bleedingnonvariceal upper gastrointestinal bleeding
JPRN-UMIN000023467shonan kamakura general hospital100
招募中
1 期
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTEacute venous thromboembolism eventMedDRA version: 21.1Level: LLTClassification code: 10049918Term: Deep venous thrombosis proximal Class: 10047065MedDRA version: 20.0Level: LLTClassification code: 10014521Term: Embolism pulmonary Class: 10038738MedDRA version: 21.1Level: LLTClassification code: 10067625Term: Secondary prevention Class: 10042613MedDRA version: 21.1Level: LLTClassification code: 10051615Term: Atherosclerotic cardiovascular disease Class: 10047065
CTIS2022-500974-33-00CHU De Saint Etienne1,400
已完成
不适用
The prospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.Cardiovascular diseases
JPRN-UMIN000022471Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine / Tohoku Heart Failure Association7,274